Café

© 2026 Longbridge｜Terms of Service Privacy Policy

300122

300122

13.730.66%( +0.09 )

LongbridgeAI

ZHIFEI-BIOL: The recombinant varicella-zoster virus ZFA01 adjuvanted vaccine (CHO cells) has received the clinical trial approval notice

Wallstreetcn

Feb 9, 2026 at 08:09 AM

ZHIFEI-BIOL: The recombinant varicella-zoster virus ZFA01 adjuvanted vaccine (CHO cells) has received the clinical trial approval notice

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

ZHIFEI-BIOL

300122.SZ

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--